Back to search

Article

Development of Prognostic Signature Based on Pan-cancer Proteomics

2020-05-27

Abstract excerpt

<title>Abstract</title> <p><bold>Background: </bold>Utilizing genomic data to predict cancer prognosis was insufficient. Proteomics can improve our understanding of the etiology and progression of cancer and improve the assessment of cancer prognosis. Based on CPTAC (Clinical Proteomic Tumor Analysis Consortium) which has generated extensive proteomics data of the vast majority of tumors, we can perform a proteom...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c5df6c8f-ae04-54e9-bb9c-4ece81bb5885
DOI
10.21203/rs.3.rs-30886/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Development of Prognostic Signature Based on Pan-cancer ProteomicsDOI 10.21203/rs.3.rs-30886/v1
Select a neighboring publication to make it the new centre.